02.25.14
Columbia, Md.-based regenerative medicine company ACell Inc. has launched its new Matristem multilayer wound matrix device for deep, hard-to-heal, full-thickness wounds. The 1:1 mesh design of Matristem is built to accommodate moderate to heavy wound exudate and provides effective contouring functionality in wound application.
Matristem products are designed to maintain and support a healing environment through constructive remodeling. Matristem is comprised of naturally-occurring urinary bladder matrix, intended to maintain an intact epithelial basement membrane which is hypothesized to facilitate the body’s natural healing potential.
The Matristem Multilayer Wound Matrix device does not require and special handling or storage requirements, and is touted as appropriate for both acute and chronic wounds.
“ACell has developed Matristem multilayer wound matrix to address an unmet need in the area of acute and chronic wound care management,” said Jim DeFrancesco, CEO and board director of ACell. “The launch of this new product provides a new option for physicians treating patients suffering from deep, hard-to-heal wounds.”
Matristem devices have received multiple 510(k) clearances from the U.S. Food and Drug Administration and are indicated for wound management including for pressure ulcers, venous ulcers, diabetic ulcers, surgical wounds and trauma wounds, and the reinforcement of soft tissue where weakness exists in urological, gynecological and gastroenterological anatomy.
The Matristem portfolio also recently underwent an expansion, as ACell added four new sizes to the pelvic floor matrix set of devices. The Matristem pelvic floor matrix is a naturally-occuring, non-synthetic scaffold designed to provide a balance of strength and pliability for use in repair of anterior, posterior and apical defects. It is intended for implantation to reinforce soft tissue where weakness exists in urological and gynecological anatomy including vaginal prolapse repair, reconstruction of pelvic floor, and pubo-urethral support. These devices have been on the market since 2010.
Matristem products are designed to maintain and support a healing environment through constructive remodeling. Matristem is comprised of naturally-occurring urinary bladder matrix, intended to maintain an intact epithelial basement membrane which is hypothesized to facilitate the body’s natural healing potential.
The Matristem Multilayer Wound Matrix device does not require and special handling or storage requirements, and is touted as appropriate for both acute and chronic wounds.
“ACell has developed Matristem multilayer wound matrix to address an unmet need in the area of acute and chronic wound care management,” said Jim DeFrancesco, CEO and board director of ACell. “The launch of this new product provides a new option for physicians treating patients suffering from deep, hard-to-heal wounds.”
Matristem devices have received multiple 510(k) clearances from the U.S. Food and Drug Administration and are indicated for wound management including for pressure ulcers, venous ulcers, diabetic ulcers, surgical wounds and trauma wounds, and the reinforcement of soft tissue where weakness exists in urological, gynecological and gastroenterological anatomy.
The Matristem portfolio also recently underwent an expansion, as ACell added four new sizes to the pelvic floor matrix set of devices. The Matristem pelvic floor matrix is a naturally-occuring, non-synthetic scaffold designed to provide a balance of strength and pliability for use in repair of anterior, posterior and apical defects. It is intended for implantation to reinforce soft tissue where weakness exists in urological and gynecological anatomy including vaginal prolapse repair, reconstruction of pelvic floor, and pubo-urethral support. These devices have been on the market since 2010.